Quinlan Steven J. 4
4 · NEOGEN CORP · Filed Apr 1, 2021
Insider Transaction Report
Form 4
NEOGEN CORPNEOG
Quinlan Steven J.
VP & CFO
Transactions
- Sale
Common Stock
2021-03-31$88.07/sh−15,000$1,321,058→ 13,470 total - Exercise/Conversion
Common Stock
2021-03-31$60.43/sh+15,000$906,413→ 28,470 total - Exercise/Conversion
Common Stock (Right to Buy)
2021-03-31−15,000→ 116,999 totalExercise: $60.43Exp: 2022-11-27→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]Options were granted on 10/27/2017, have five year lives, and vest in equal annual 20% installments on each of the first five anniversary dates of the grant